9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy.

      Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
      Aspirin, Aged, Aged, 80 and over, Anticoagulants, adverse effects, Female, Fibrinolytic Agents, Glasgow Coma Scale, Hematoma, Subdural, Chronic, chemically induced, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Warfarin

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Eighty-one cases of chronic subdural haematomas (CSDH) admitted to the neurosurgical unit of the Royal Hobart Hospital, Tasmania, Australia, over a 5-year period were reviewed. The use of anticoagulant therapy as a causative agent in the development of CSDH was investigated. We suspected a high incidence of anticoagulant or anti-thrombotic therapy. We found that anticoagulant therapy was used by a significant percentage of CSDH patients. In the patient group presenting to our unit the risk of developing a CSDH was at least 42.5 times higher in warfarinised patients and also increased for patients on aspirin, although this risk could not be quantified.

          Related collections

          Author and article information

          Comments

          Comment on this article